Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 8/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.81 |
| ▸ | SLC10A2 | Q12908 | 2/20 | 0.81 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.81 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.81 |
| ▸ | VDR | P11473 | 1/20 | 0.80 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.80 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.77 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | CA1 | P00915 | 5/20 | 0.68 |
| ▸ | CA2 | P00918 | 5/20 | 0.68 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycodeoxycholate SCHEMBL27652429 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL13851639 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL26088647 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL23704979 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL1218231 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL23704978 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL4301 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL23710381 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL20955852 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL24840 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8102 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122084906-A | Plasma metabolism marker for early diagnosis or prediction of gestational diabetes mellitus and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260139227-A1 | ADIPOSE-DERIVED REGENERATIVE CELL PREPARATIONS | BLUE CELL THERAPEUTICS APS (DK) | 2026-05-21 | — | — | US | claimed |
| CN-122056828-A | Industrial preparation method of vitamin K1 micelle injection preparation | 浙江创新生物有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| CN-122017068-A | Bile acid high-flux detection method based on ultra-high performance liquid chromatography tandem mass spectrometry and application thereof | 青岛百谱生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12569502-B2 | Use of bile acids and derivatives thereof in preparation of GPR39 agonist | PEKING UNIVERSITY (CN) | 2026-03-10 | — | — | US | claimed |
| EP-4701625-A2 | FORMULATION OF THERAPEUTIC AGENTS FOR IMPROVED PERMEATION | Vivtex Corporation (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4262876-B1 | COVALENTLY MODIFIED ANTIGENS FOR IMPROVED IMMUNE RESPONSE AND/OR STABILITY | DEFENCE THERAPEUTICS INC (CA) | 2026-02-25 | — | — | EP | claimed |
| EP-4676444-A1 | NANOPARTICLE FORMULATIONS FOR A NON-OPIOID DRUG | South Rampart Pharma (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260007687-A1 | ALPHAXALONE FAT EMULSION INJECTION AND METHOD FOR PREPARING SAME | JIANGSU NHWA PHARMACEUTICAL CO., LTD (CN) | 2026-01-08 | — | — | US | claimed |
| EP-0272578-B1 | MULTILAYER ANALYSIS ELEMENTS FOR THE DETERMINATION OF TOTAL CHOLESTEROL | Fuji Photo Film Co., Ltd. (JP) | 1993-03-24 | — | — | EP | claimed |
| US-5182258-A | Passage into nasolacrimal duct and absorption into circulation | ORBON CORPORATION (US) | 1993-01-26 | — | — | US | claimed |
| US-5085864-A | Erythromycins and derivatives, bile salts; less painful at injection site | ABBOTT LABORATORIES (US) | 1992-02-04 | — | — | US | claimed |
| EP-0426029-A1 | Injectable formulation for lipophilic drugs | ABBOTT LABORATORIES (US) | 1991-05-08 | — | — | EP | claimed |
| US-5010056-A | Growth disorders | PIERREL SPA (IT) | 1991-04-23 | — | — | US | claimed |
| US-4990457-A | Porous spreading layer containing cholic acid, deoxycholic acid or salts; accuracy | FUJI PHOTO FILM CO., LTD. (JP) | 1991-02-05 | — | — | US | claimed |
| EP-0301392-A1 | Pharmaceutical composition for intranasal administration comprising GH - Releasing hormone, a cholinergic agonist and in case a bile salt | Pierrel S.p.A. (IT) | 1989-02-01 | — | — | EP | claimed |
| EP-0272578-A2 | Multilayer analysis elements for the determination of total cholesterol | Fuji Photo Film Co., Ltd. (JP) | 1988-06-29 | — | — | EP | claimed |
| US-4164573-A | INSULIN | GALINSKY ALVIN M | 1979-08-14 | — | — | US | claimed |
| US-4158707-A | Parenteral preparations | HOFFMANN-LA ROCHE INC. (US) | 1979-06-19 | — | — | US | claimed |